105 related articles for article (PubMed ID: 20615624)
1. Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
Créhange G; Parfait S; Liegard M; Maingon P; Ben Salem D; Cochet A; Funes de la Vega M; Cormier L; Bonnetain F; Mirjolet C; Brunotte F; Walker PM
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1087-94. PubMed ID: 20615624
[TBL] [Abstract][Full Text] [Related]
2. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
[TBL] [Abstract][Full Text] [Related]
3. Reduced power magnetic resonance spectroscopic imaging of the prostate at 4.0 Tesla.
Near J; Romagnoli C; Bartha R
Magn Reson Med; 2009 Feb; 61(2):273-81. PubMed ID: 19165876
[TBL] [Abstract][Full Text] [Related]
4. 3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.
Kirilova A; Damyanovich A; Crook J; Jezioranski J; Wallace K; Pintilie M
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):371-8. PubMed ID: 20421147
[TBL] [Abstract][Full Text] [Related]
5. (31) P MR spectroscopic imaging combined with (1) H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T.
Luttje MP; Italiaander MG; Arteaga de Castro CS; van der Kemp WJ; Luijten PR; van Vulpen M; van der Heide UA; Klomp DW
Magn Reson Med; 2014 Dec; 72(6):1516-21. PubMed ID: 24357271
[TBL] [Abstract][Full Text] [Related]
6. Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil.
Kaji Y; Wada A; Imaoka I; Matsuo M; Terachi T; Kobashi Y; Sugimura K; Fujii M; Maruyama K; Takizawa O
J Magn Reson Imaging; 2002 Dec; 16(6):697-706. PubMed ID: 12451583
[TBL] [Abstract][Full Text] [Related]
7. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging.
Coakley FV; Chen I; Qayyum A; Westphalen AC; Carroll PR; Hricak H; Chen MH; Kurhanewicz J
BJU Int; 2007 Jan; 99(1):41-5. PubMed ID: 17227490
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging.
Kurhanewicz J; Vigneron DB; Hricak H; Parivar F; Nelson SJ; Shinohara K; Carroll PR
Radiology; 1996 Aug; 200(2):489-96. PubMed ID: 8685346
[TBL] [Abstract][Full Text] [Related]
9. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
10. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
[TBL] [Abstract][Full Text] [Related]
11. A phase and frequency alignment protocol for 1H MRSI data of the prostate.
Wright AJ; Buydens LM; Heerschap A
NMR Biomed; 2012 May; 25(5):755-65. PubMed ID: 21953616
[TBL] [Abstract][Full Text] [Related]
12. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification.
Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A
PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096
[TBL] [Abstract][Full Text] [Related]
13. [Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results].
Stanka M; Eltze E; Semjonow A; Sievert KD; Maier A; Pfleiderer B
Rofo; 2000 Jul; 172(7):623-9. PubMed ID: 10962989
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level.
Pickett B; Kurhanewicz J; Pouliot J; Weinberg V; Shinohara K; Coakley F; Roach M
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):65-72. PubMed ID: 16517094
[TBL] [Abstract][Full Text] [Related]
15. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
[TBL] [Abstract][Full Text] [Related]
16. 2D JPRESS of human prostates using an endorectal receiver coil.
Yue K; Marumoto A; Binesh N; Thomas MA
Magn Reson Med; 2002 Jun; 47(6):1059-64. PubMed ID: 12111951
[TBL] [Abstract][Full Text] [Related]
17. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
Zakian KL; Eberhardt S; Hricak H; Shukla-Dave A; Kleinman S; Muruganandham M; Sircar K; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
Radiology; 2003 Oct; 229(1):241-7. PubMed ID: 12920178
[TBL] [Abstract][Full Text] [Related]
18. [Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications].
Franiel T
Rofo; 2011 Jul; 183(7):607-17. PubMed ID: 21487980
[TBL] [Abstract][Full Text] [Related]
19. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M
Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer.
Saito K; Kaminaga T; Muto S; Ide H; Nishio K; Kamiyama Y; Okada H; Terado Y; Furui S; Horie S
Anticancer Res; 2008; 28(3B):1899-904. PubMed ID: 18630478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
